Role of immunosuppressive therapy in refractory sprue-like disease

Citation
P. Rolny et al., Role of immunosuppressive therapy in refractory sprue-like disease, AM J GASTRO, 94(1), 1999, pp. 219-225
Citations number
22
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN journal
00029270 → ACNP
Volume
94
Issue
1
Year of publication
1999
Pages
219 - 225
Database
ISI
SICI code
0002-9270(199901)94:1<219:ROITIR>2.0.ZU;2-0
Abstract
Patients with malabsorption and histological findings consistent with celia c disease, who are unresponsive to gluten free diet, and in whom other caus es of flat mucosa have been excluded, are considered to suffer from so call ed unclassified or refractory sprue, Although the true nature of this condi tion needs to be further elucidated, it is known to represent a difficult t herapeutical problem with potentially fatal course. Herein, me report a pat ient with refractory sprue-like disease who after failing to respond to cor ticosteroids and TPN was in a critical condition. He responded promptly to cyclosporine and made a remarkable recovery. In contrast to previous report s, the cyclosporine treatment in this patient was pursued only for 1 month, whereupon the patient turned responsive to steroids. Subsequent treatment with azathioprine allowed corticosteroids to be reduced to a low maintenanc e dose and eventually all drugs could be discontinued without reappearance of symptoms. Cyclosporine therapy might be lifesaving in occasional patient s with refractory sprue-like disease and it may result in reversal of stero id resistance. moreover azathioprine seems to have a steroid sparing effect in this setting. Short term immunosuppressive treatment may have an advant age of lower risk for drug related side effects. (C) 1999 by Am. Coll. of G astroenterology.